Gross margin moved 168 bp lower
Gross margin changed -168 basis points from the comparable as-filed period.
20.46%→18.79%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →HPQ financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue increased 12.5%
Revenue changed +12.5% from the comparable as-filed period.
$13.9B→$15.7B2 prior comparisons
Receivables / revenue moved 895 bp higher
Receivables / revenue changed +895 basis points from the comparable as-filed period.
36.77%→45.72%2 prior comparisons
Shares outstanding decreased 3.5%
Shares outstanding changed -3.5% from the comparable as-filed period. The change ranks at the 71th percentile of 7 prior comparable changes.
934,701,851→901,790,9697 prior comparisons
Debt / revenue moved 1022 bp lower
Debt / revenue changed -1022 basis points from the comparable as-filed period.
68.91%→58.68%2 prior comparisons
Working capital / assets moved 250 bp higher
Working capital / assets changed +250 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-18.29%→-15.79%4 prior comparisons
Operating margin moved 55 bp higher
Operating margin changed +55 basis points from the comparable as-filed period.
5.14%→5.69%2 prior comparisons
Cost of revenue increased 14.9%
Cost of revenue changed +14.9% from the comparable as-filed period.
$11.1B→$12.7B2 prior comparisons
Gross debt decreased 4.2%
Gross debt changed -4.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$9.6B→$9.2B4 prior comparisons
Reported total debt decreased 4.2%
Reported total debt changed -4.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$9.6B→$9.2B4 prior comparisons
Current ratio increased 6.7%
Current ratio changed +6.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
0.74→0.794 prior comparisons
Capex / revenue moved 35 bp lower
Capex / revenue changed -35 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.54%→1.19%2 prior comparisons
Free-cash-flow proxy increased 7.1%
Free-cash-flow proxy changed +7.1% from the comparable as-filed period.
$1.4B→$1.5B2 prior comparisons
Noncurrent long-term debt decreased 10.4%
Noncurrent long-term debt changed -10.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.8B→$7.9B4 prior comparisons
Operating cash flow increased 4.5%
Operating cash flow changed +4.5% from the comparable as-filed period.
$1.7B→$1.7B2 prior comparisons
SBC / revenue moved 11 bp lower
SBC / revenue changed -11 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
0.72%→0.61%2 prior comparisons
Stock-based compensation decreased 5.0%
Stock-based compensation changed -5.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$100.0M→$95.0M2 prior comparisons
Capital expenditure decreased 13.0%
Capital expenditure changed -13.0% from the comparable as-filed period.
$215.0M→$187.0M2 prior comparisons
Research & development decreased 4.2%
Research & development changed -4.2% from the comparable as-filed period.
$406.0M→$389.0M2 prior comparisons
Selling, general & administrative increased 5.9%
Selling, general & administrative changed +5.9% from the comparable as-filed period.
$1.5B→$1.5B2 prior comparisons
Operating cash-flow margin moved 86 bp lower
Operating cash-flow margin changed -86 basis points from the comparable as-filed period.
11.92%→11.07%2 prior comparisons
Free-cash-flow margin moved 50 bp lower
Free-cash-flow margin changed -50 basis points from the comparable as-filed period.
10.38%→9.87%2 prior comparisons
Working capital increased 1.0%
Working capital changed +1.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
-$7.3B→-$7.2B4 prior comparisons
R&D / revenue moved 43 bp lower
R&D / revenue changed -43 basis points from the comparable as-filed period.
2.91%→2.48%2 prior comparisons
Gross profit increased 3.3%
Gross profit changed +3.3% from the comparable as-filed period.
$2.9B→$2.9B2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.